This guide intends to educate clinicians and other stakeholders about the harms of using more than one substance and consideration for addressing concurrent substance use (CSU) and concurrent substance use disorders (CSUD).
You May Also Be Interested In
TIP 42: Substance Use Treatment for Persons With Co-Occurring Disorders
Advisory: Substance Use Disorder Treatment for People with Co-Occurring Disorders
This Advisory is based on TIP 42, Substance Use Disorder Treatment for People with Co-Occurring Disorders. It highlights strategies for counselors and administrators to properly screen, assess, diagnose, and manage the treatment of individuals with co-occurring substance use and mental disorders.
TIP 63: Medications for Opioid Use Disorder - Full Document
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
Treatment for Youth and Young Adults with Mood Disorders and other Serious Emotional Disturbances and Co-occurring Substance Use
First-Episode Psychosis and Co-Occurring Substance Use Disorders
This guide supports health care providers, systems, and communities to address first-episode psychosis and co-occurring substance use disorders. It describes relevant research, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers resources.